CD4
CD4+ T cells
HIV
Hodgkin’s lymphoma
antiretroviral therapy
tuberculosis
Journal
Open life sciences
ISSN: 2391-5412
Titre abrégé: Open Life Sci
Pays: Poland
ID NLM: 101669614
Informations de publication
Date de publication:
2023
2023
Historique:
received:
21
06
2023
revised:
29
08
2023
accepted:
04
09
2023
medline:
25
9
2023
pubmed:
25
9
2023
entrez:
25
9
2023
Statut:
epublish
Résumé
In the human immunodeficiency virus (HIV)-infected population, especially HIV with concomitant tuberculosis (TB) or Hodgkin's lymphoma (HL), numerous risk factors have been reported in recent years. Among them, the decreased CD4
Identifiants
pubmed: 37744454
doi: 10.1515/biol-2022-0744
pii: biol-2022-0744
pmc: PMC10512445
doi:
Types de publication
Case Reports
Langues
eng
Pagination
20220744Informations de copyright
© 2023 the author(s), published by De Gruyter.
Déclaration de conflit d'intérêts
Conflict of interest: Authors state no conflict of interest.
Références
Front Mol Biosci. 2021 Oct 20;8:692823
pubmed: 34746228
Clin Infect Dis. 2010 May 15;50 Suppl 3:S215-22
pubmed: 20397951
Haematologica. 2007 Feb;92(2):191-8
pubmed: 17296568
S Afr Med J. 2018 Jun 26;108(7):653-567
pubmed: 30004343
Clin Lymphoma Myeloma. 2007 Mar;7(5):364-8
pubmed: 17562247
J Virol. 2019 Feb 19;93(5):
pubmed: 30541853
J Acquir Immune Defic Syndr. 2020 Apr 1;83(4):345-349
pubmed: 32097194
J Natl Cancer Inst. 2022 Jun 13;114(6):854-862
pubmed: 35292820
Pathogens. 2020 Aug 14;9(8):
pubmed: 32823923
Cell Rep. 2019 Apr 2;27(1):142-153.e4
pubmed: 30943397
Clin Infect Dis. 2013 Jul;57(2):314-21
pubmed: 23575194
J Family Med Prim Care. 2020 Feb 28;9(2):1160-1165
pubmed: 32318485
Annu Rev Immunol. 2013;31:475-527
pubmed: 23516984
World J Virol. 2015 Aug 12;4(3):209-18
pubmed: 26279983
Lancet HIV. 2023 Apr;10(4):e269-e272
pubmed: 37001965
PLoS One. 2013 Aug 01;8(8):e70250
pubmed: 23936398
J Int AIDS Soc. 2023 Mar;26(3):e26070
pubmed: 36880429
J Clin Oncol. 2012 Nov 20;30(33):4117-23
pubmed: 23045592
Pathogens. 2022 Dec 16;11(12):
pubmed: 36558886
Molecules. 2023 Apr 10;28(8):
pubmed: 37110574
Clin Infect Dis. 2015 Nov 1;61(9):1469-75
pubmed: 26223997
AIDS. 2016 Mar 13;30(5):753-60
pubmed: 26605513
BMC Med Res Methodol. 2022 Nov 18;22(1):295
pubmed: 36401214
Clin Microbiol Rev. 2011 Apr;24(2):351-76
pubmed: 21482729
Ann Hematol. 2019 Feb;98(2):381-389
pubmed: 30397846
BMC Infect Dis. 2016 Oct 17;16(1):572
pubmed: 27751168
J Int Soc Prev Community Dent. 2020 Jan 24;10(1):21-35
pubmed: 32181218
J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):487-94
pubmed: 24820105
Lancet HIV. 2017 Feb;4(2):e67-e73
pubmed: 27916584
Blood Lymphat Cancer. 2022 Apr 29;12:31-45
pubmed: 35517869
Immunity. 2023 May 9;56(5):1132-1147.e6
pubmed: 37030290
JCO Glob Oncol. 2022 Jan;8:e2100163
pubmed: 35025689
Cancers (Basel). 2021 Aug 29;13(17):
pubmed: 34503176
J Infect Dis. 2016 Oct 1;214 Suppl 2:S51-7
pubmed: 27625431
AIDS. 2022 May 1;36(6):795-804
pubmed: 35013083
PLoS One. 2016 Mar 09;11(3):e0150941
pubmed: 26959228
Mediterr J Hematol Infect Dis. 2019 Jan 01;11(1):e2019004
pubmed: 30671210
Clin Infect Dis. 2023 Jun 8;76(11):2027-2037
pubmed: 36975712
Curr Opin Immunol. 2014 Aug;29:137-42
pubmed: 25000593